Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Center for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC), Houston, TX, USA.
J Thromb Haemost. 2019 Jun;17(6):866-877. doi: 10.1111/jth.14426. Epub 2019 Apr 5.
Essentials Platelet adhesion to von Willebrand factor (VWF) is critical for hemostasis and thrombosis. Whether VWF can undergo phosphorylation is unknown. Family with sequence similarity 20 kinase phosphorylates VWF A2 domain at S1517 and S1613. Phosphorylation of VWF and VWF A1A2A3 domain at S1613 enhances platelet adhesion. SUMMARY: Background von Willebrand factor (VWF) mediates platelet adhesion and contributes to hemostasis at sites of vascular injury as well as to arterial thrombosis. The A1A2A3 domains of VWF contain important sites that differentially participate in supporting platelet adhesion. FAM20c (family with sequence similarity 20, member C) has emerged as a serine/threonine kinase, which phosphorylates extracellular proteins containing the S-X-E/pS motifs that are also found within the VWF A domains. This is of interest because we and others have shown that structural modifications within these A domains influence the ability of VWF to support platelet adhesion. Objective We assessed if VWF A domains can be phosphorylated and the functional consequence of phosphorylated VWF. Results Here, we show that FAM20c phosphorylated purified plasma VWF, VWF A1A2A3 protein, isolated A2 domain, but not A1 and A3 domain proteins, in vitro. FAM20c phosphorylated the isolated A2 domain at S1517 and S1613 within the S-X-E recognition motif, with S1613 being the major phosphorylation site. Mass spectrometry analysis of purified plasma VWF from healthy donors revealed several phosphorylation sites, including the S1613 in the A2 domain. VWF A1A2A3 domain protein phosphorylated at S1613 promoted stable platelet adhesion and microthrombi at high shear stress. Lastly, under high shear stress VWF treated with FAM20c and ATP robustly supported platelet adhesion, compared to VWF treated with FAM20c in the absence of ATP. Conclusion These outcomes indicate that VWF can be phosphorylated by FAM20c in vitro, and this novel post-translational modification enhances the adhesiveness of VWF to platelets.
血小板黏附于血管性血友病因子(VWF)对于止血和血栓形成至关重要。目前尚不清楚 VWF 是否可以发生磷酸化。家族性 20 号激酶通过 S1517 和 S1613 磷酸化 VWF A2 结构域。VWF 和 VWF A1A2A3 结构域的 S1613 磷酸化增强血小板黏附。
背景:血管性血友病因子(VWF)介导血小板黏附,在血管损伤部位参与止血,并促进动脉血栓形成。VWF 的 A1A2A3 结构域包含重要的位点,这些位点差异参与支持血小板黏附。家族性 20 号激酶 C(family with sequence similarity 20,member C,FAM20C)是一种丝氨酸/苏氨酸激酶,可磷酸化含有 S-X-E/pS 基序的细胞外蛋白,这些基序也存在于 VWF A 结构域内。这一点很有趣,因为我们和其他人已经表明,这些 A 结构域内的结构修饰会影响 VWF 支持血小板黏附的能力。
我们评估 VWF A 结构域是否可以磷酸化,以及磷酸化 VWF 的功能后果。
在此,我们证明 FAM20c 在体外可使纯化的血浆 VWF、VWF A1A2A3 蛋白、分离的 A2 结构域,但不能使 A1 和 A3 结构域蛋白磷酸化。FAM20c 在 S-X-E 识别基序内的 S1517 和 S1613 磷酸化分离的 A2 结构域,其中 S1613 是主要的磷酸化位点。对健康供体的纯化血浆 VWF 的质谱分析显示了几个磷酸化位点,包括 A2 结构域中的 S1613。在高剪切应力下,磷酸化 S1613 的 VWF A1A2A3 结构域蛋白促进稳定的血小板黏附并形成微血栓。最后,与没有 ATP 的 FAM20c 处理的 VWF 相比,在高剪切应力下,与 FAM20c 和 ATP 一起处理的 VWF 可显著支持血小板黏附。
这些结果表明,VWF 可以在体外被 FAM20c 磷酸化,这种新的翻译后修饰增强了 VWF 与血小板的黏附能力。